Chiesi España & Portugal

About Chiesi España & Portugal

Chiesi is an international research-focused biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialized care. Our mission is to improve people's quality of life and act responsibly for the benefit of the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the USA, and France, Chiesi's commitment to creating shared value for society as a whole is legally binding and central to the company's decision-making. As a certified B Corp since 2019, we are part of a global community of companies that meet high standards of social and environmental impact. The company aims to achieve net-zero greenhouse gas (GHG) emissions by 2035. With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 31 countries, and has more than 6,000 employees. The Group's R&D center in Parma works alongside 6 other major R&D centers in France, the United States, Canada, China, the United Kingdom, and Sweden. To report adverse reactions or concerns about the safety of any of our medicines, please contact the Pharmacovigilance Department of Laboratorios Chiesi at farmacovigilancia@chiesi.com or at +34 934 948 000. CHIESI ESPAÑA, S.A.U. is responsible for processing your personal data. CHIESI will process your personal data to manage interactions between you and CHIESI through the information you provide on social networks where CHIESI has an active profile, and to comply with legal obligations related to the communication of adverse reactions. For information on how we process your personal data and how to exercise your rights, please refer to the Privacy Policy at this link: https://bit.ly/3oaChCm